Item 5. Other Information
Item 5. Other Information.
None.
26
Item 6. Exhibits
Exhibit
No.
Description
31.1
Certification of Chief Executive Officer of the Company in accordance with Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
31.2
Certification of Chief Financial Officer of the Company in accordance with Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
32.1
Certification of Chief Executive Officer and Chief Financial Officer of the Company in accordance with Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
99.1
Press Release for Quarter Ended March 31, 2021 (filed herewith).
101.1
Interactive Data File
27
SIGNATURES
Pursuant to requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Fennec Pharmaceuticals Inc.
Date: May 13, 2021
By:
/s/ Rostislav Raykov
Rostislav Raykov
Chief Executive Officer
(principal executive officer)
Date: May 13, 2021
By:
/s/ Robert Andrade
Robert Andrade
Chief Financial Officer
(principal financial and chief accounting officer)
28
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.